Aethlon Medical, Inc (AEMD) Market Capitalization Is $78.73M, while its Gross Profit (TTM) is $650,187
Aethlon Medical, Inc (NASDAQ: AEMD) opened the trading session on June 11, 2021, at $6.91, showing a change of -5.9420% against the previous close at $6.9. During the trading session, the stock price increased to $7.13 and dropped to $6.2. Finally, the stock adjusted at $6.49. Nevertheless, taking into consideration a long-term perspective, Aethlon Medical, Inc reported a 52 Week Range within the ambit of $1.22-$7.13.
Aethlon Medical, Inc's shares outstanding currently value $12.13M, as well as with a float of $12.03M. AEMD operates in the Healthcare sector of the Medical Devices industry and has a market capitalization of $78.73M (as of June 11, 2021). Also worth noting that Aethlon Medical, Inc's 50-day Moving Average adjusted at $2.25, while such sign as 200-day Moving Average is at the present time $2.23.
To rate the company's efficiency, let's focus attention on Aethlon Medical, Inc's conglomerate performance. Currently, AEMD has 8 full-time employees. Aethlon Medical, Inc has generated $81,273.375 per worker During the last fiscal year. In the interim, AEMD's income per employee was $-796,743.500. And now, let's focus attention on the company's income report. Aethlon Medical, Inc's Net Income for the last fiscal year was $-6,373,948, while such sign as Income Before Taxes was at the level of $-6,380,041. AEMD's Operating Income was at the mark of $-5,929,988.
Aethlon Medical, Inc (AEMD) Earnings & Revenue
Talking about the Profitability, AEMD reached a Profit Margin of 0% and an Operating Margin (TTM) of -891.12%. However, when we touch the questions of management effectiveness, Aethlon Medical, Inc generated a Return on Equity (TTM) of -97.28% and a Return on Assets (TTM) of -53.38%. A bit more income statements might bring clarity to our overview. According to the results of the latest quarter ended December 31, 2020, Aethlon Medical, Inc generated Revenue (TTM) of $831,600, reporting a Quarterly Revenue Growth of 51.1%. As for the Revenue Per Share (TTM), this indicator was at the mark of $0.079. The company's Gross Profit (TTM) was $650,187, while according to the EBITDA report, it was estimated at $-5,969,840.
Aethlon Medical, Inc (NASDAQ: AEMD) Owners & Shares
Finally, let's take a look at the share statistics. As mentioned above, AEMD's shares outstanding now amounts to $12.13M, where Shares Short was $215,360 versus the prior month amounted to $237,307. (Short % of Float was 1.79%). And now, let's overview which kind of investors works with Aethlon Medical, Inc's stocks. AEMD's current ownership accounts for 8.409% institutional investors, while 1.993% of shares belong to the insiders. Also worth mentioning some indicators affecting dividends & splits. Thus, AEMD's Forward Annual Dividend Rate is currently at the mark of 0, whereas the Dividend Yield is 0%, and a Dividend Payout Ratio is 0% (Dividend Date: October 15, 2019). The company's Dividend Per Share sign thereby is $None.
AEMD Trading Performance
It's time to observe the current performance indicators for Aethlon Medical, Inc. AEMD's price/earnings to growth ratio during the last reported quarter was 0%. The company's PE Ratio stands at None%, while AEMD's Beta score is 0.5087. Also worth noting that Aethlon Medical, Inc's Diluted EPS (Earnings per Share) trailing twelve months is at the mark of -0.706. Other valuable indicators are Price To Sales Ratio (TTM), which is currently recorded at 87.1043, as well as Price To Book Ratio, which amounts to 7.235.
Aethlon Medical, Inc Analysis & Estimates
Within the previous 9-day period, Aethlon Medical, Inc's Average True Range (ATR) was 1.5763, while the stock's Stochastic SlowD moving average was 51.7543%, and the SlowK moving average volumed at 51.7543%.